Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis

Breast cancer is the most common cancer in women and the second most common cancer overall. Although advancements in the early diagnosis and therapy of breast cancer have occurred in recent years, the prognosis of breast cancer bone metastasis remains poor and this type of cancer is rarely cured. Th...

Full description

Bibliographic Details
Main Authors: Yu Wenhui, Xie Zhongyu, Chen Kai, Cai Zhaopeng, Li Jinteng, Ma Mengjun, Su Zepeng, Che Yunshu, Wang Peng, Wu Yanfeng, Shen Huiyong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.894283/full
_version_ 1811249040207118336
author Yu Wenhui
Xie Zhongyu
Chen Kai
Cai Zhaopeng
Li Jinteng
Ma Mengjun
Su Zepeng
Che Yunshu
Wang Peng
Wu Yanfeng
Shen Huiyong
author_facet Yu Wenhui
Xie Zhongyu
Chen Kai
Cai Zhaopeng
Li Jinteng
Ma Mengjun
Su Zepeng
Che Yunshu
Wang Peng
Wu Yanfeng
Shen Huiyong
author_sort Yu Wenhui
collection DOAJ
description Breast cancer is the most common cancer in women and the second most common cancer overall. Although advancements in the early diagnosis and therapy of breast cancer have occurred in recent years, the prognosis of breast cancer bone metastasis remains poor and this type of cancer is rarely cured. The gut microbiota is indispensable for internal homeostasis and regulates various biological processes. Understanding the gut microbiota profiles in normal controls (NCs), breast cancer patients with no metastasis (BNs), and breast cancer patients with bone metastasis (BMs) may shed light on the development of diagnostic and therapeutic targets for breast cancer and bone metastasis. We comprehensively analyzed the gut microbiota from NCs, BNs, and BMs and found that the community diversity decreased in the order of NCs, BNs, and BMs. Streptococcus, Campylobacter and Moraxellaceae showed higher abundances in BNs and BMs than in NCs. The lack of Megamonas and Akkermansia in the BM compared with those in the NC and BN groups was considered related to bone metastasis. Additionally, based on the distinct gut microbiota profiles, we predicted that lipid transportation and metabolism, as well as folate biosynthesis, participate in breast cancer occurrence and that steroid hormone biosynthesis influences bone metastasis. Our study demonstrated that variations in gut microbiota are associated with breast cancer occurrence and bone metastasis, providing attractive targets to develop therapeutic and diagnostic methods.
first_indexed 2024-04-12T15:38:18Z
format Article
id doaj.art-eb25744a3420436eb0461d018e0d3723
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-12T15:38:18Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-eb25744a3420436eb0461d018e0d37232022-12-22T03:26:53ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-05-011310.3389/fmicb.2022.894283894283Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone MetastasisYu Wenhui0Xie Zhongyu1Chen Kai2Cai Zhaopeng3Li Jinteng4Ma Mengjun5Su Zepeng6Che Yunshu7Wang Peng8Wu Yanfeng9Shen Huiyong10Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaBreast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaCenter for Biotherapy, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaDepartment of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, ChinaBreast cancer is the most common cancer in women and the second most common cancer overall. Although advancements in the early diagnosis and therapy of breast cancer have occurred in recent years, the prognosis of breast cancer bone metastasis remains poor and this type of cancer is rarely cured. The gut microbiota is indispensable for internal homeostasis and regulates various biological processes. Understanding the gut microbiota profiles in normal controls (NCs), breast cancer patients with no metastasis (BNs), and breast cancer patients with bone metastasis (BMs) may shed light on the development of diagnostic and therapeutic targets for breast cancer and bone metastasis. We comprehensively analyzed the gut microbiota from NCs, BNs, and BMs and found that the community diversity decreased in the order of NCs, BNs, and BMs. Streptococcus, Campylobacter and Moraxellaceae showed higher abundances in BNs and BMs than in NCs. The lack of Megamonas and Akkermansia in the BM compared with those in the NC and BN groups was considered related to bone metastasis. Additionally, based on the distinct gut microbiota profiles, we predicted that lipid transportation and metabolism, as well as folate biosynthesis, participate in breast cancer occurrence and that steroid hormone biosynthesis influences bone metastasis. Our study demonstrated that variations in gut microbiota are associated with breast cancer occurrence and bone metastasis, providing attractive targets to develop therapeutic and diagnostic methods.https://www.frontiersin.org/articles/10.3389/fmicb.2022.894283/fullgut microbiotabone metastasis (BM)breast cancer neoadjuvant therapy16S rRNA sequencingPICRUSt (functional genes)
spellingShingle Yu Wenhui
Xie Zhongyu
Chen Kai
Cai Zhaopeng
Li Jinteng
Ma Mengjun
Su Zepeng
Che Yunshu
Wang Peng
Wu Yanfeng
Shen Huiyong
Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
Frontiers in Microbiology
gut microbiota
bone metastasis (BM)
breast cancer neoadjuvant therapy
16S rRNA sequencing
PICRUSt (functional genes)
title Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
title_full Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
title_fullStr Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
title_full_unstemmed Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
title_short Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
title_sort variations in the gut microbiota in breast cancer occurrence and bone metastasis
topic gut microbiota
bone metastasis (BM)
breast cancer neoadjuvant therapy
16S rRNA sequencing
PICRUSt (functional genes)
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.894283/full
work_keys_str_mv AT yuwenhui variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT xiezhongyu variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT chenkai variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT caizhaopeng variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT lijinteng variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT mamengjun variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT suzepeng variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT cheyunshu variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT wangpeng variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT wuyanfeng variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis
AT shenhuiyong variationsinthegutmicrobiotainbreastcanceroccurrenceandbonemetastasis